BIO-AI, Inc. develops AI-driven world models to simulate human biology across multiple scales. The company builds programmable virtual cells and a general-purpose cell biology simulator to accelerate research and discovery for medicine, biotechnology, and life sciences.
Subscribe to see BIO-AI, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
BIO-AI, Inc. is an ai/ml company headquartered in United States. Its most recent funding round raised $10M in August 2023. Xcout tracks 8 named people at BIO-AI, Inc., including Fred Hu (Co-Founder and CEO). Xcout recorded 5 job postings from BIO-AI, Inc. in the last 90 days, naming tools such as Palo Alto Networks.
2 more named people on record for BIO-AI, Inc., with roles, board committees and tenure — see the full roster →
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $10M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Xcout recorded 5 job postings from BIO-AI, Inc. in the last 90 days, from a hiring record Xcout has kept since August 2026.
The weekly hiring trend, the roles and locations behind it — see BIO-AI, Inc.'s hiring signals →
A few of BIO-AI, Inc.'s closest competitors — see the full list of competitors and alternatives →
AI Vivo is an early-stage biotechnology research startup headquartered in Cambridge, England. The company specializes in designing artificial intelligence systems and utilizing multi-modal omics data to map organ-level disease biology.
Latent Labs Technologies operates as a frontier artificial intelligence laboratory that builds generative models for molecular biology. The company provides AI-driven tools and agents—such as Latent-Y, Latent-X2, and Latent-X—to help researchers and partners design drugs, create antibodies, optimize enzymes, and advance genetic engineering.
Astromech AI Corp. is developing an autonomous biological intelligence system, termed the Large Life Model, which integrates deep learning with evolutionary biology. The platform is designed to process multi-species transcriptomic and genomic data to assist researchers in therapeutic development, trait optimization, and systems biology.
DenovAI Biotech Ltd is an Israeli biotechnology startup founded in 2023 and operated through the AION Labs venture studio in Rehovot. The company develops a generative AI and physics platform focused on the de novo design of novel proteins and therapeutic biologics.
Owkin builds artificial intelligence solutions to automate biopharmaceutical research and development and support clinical research. Its core product, K Pro, is an AI agent that analyzes multimodal patient data to generate insights, inform decision-making, and assist biopharma and healthcare professionals.
Pathos AI, Inc. is an artificial-intelligence-driven biopharmaceutical company that uses multimodal patient and biological data to discover and develop precision medicines. Its work is focused primarily on oncology and serves patients with serious diseases through pharmaceutical and healthcare partnerships.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about BIO-AI, Inc.? Suggest a correction
Post the link and the card appears automatically — each network fetches the image itself.